1976
DOI: 10.1073/pnas.73.10.3637
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of heteropolymeric hexosaminidase A in human X mouse hybrid cells.

Abstract: (19,20) suggested that there was no structural relationship between these two isozymes. We have therefore considered the possibility that the "Hex A" that occurs in mouse X human hybrids in the absence of human Hex B is, in point of fact, not human Hex A. Accordingly, we have investigated the "Hex A" activity that is found in the absence of Hex B in a human X mouse hybrid cell line that contains human chromosome 15 but not human chromosome 5. Immunological studies indicate that this "Hex A" material contains a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1977
1977
2008
2008

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 14 publications
(2 citation statements)
references
References 24 publications
0
2
0
Order By: Relevance
“…Complementation refers to a partial or complete correction of a defective function when the products of two mutant genotypes are brought together {Reuser, 1984). In many complementation studies involving human genetic diseases, cells from patients exhibiting different clinical forms of the same disease are crossed or fused in order to determine whether different gene mutations are responsible for the clinical heterogeneity seen in the disorder (Chern et al, 1976;Champion and Shows, 1977). In this way, where complementation was observed, it was shown among the sphingolipidoses that Tay-Sachs and Sandhoff GM2 gangliosidoses were due to separate genes encoding different subunits of the P-hexosaminidase enzyme (Rattazzi et al, 1976), and that sphingolipidoses can be due to structural gene or activator protein deficiencies (Kihara et al, 1984).…”
Section: Discussionmentioning
confidence: 99%
“…Complementation refers to a partial or complete correction of a defective function when the products of two mutant genotypes are brought together {Reuser, 1984). In many complementation studies involving human genetic diseases, cells from patients exhibiting different clinical forms of the same disease are crossed or fused in order to determine whether different gene mutations are responsible for the clinical heterogeneity seen in the disorder (Chern et al, 1976;Champion and Shows, 1977). In this way, where complementation was observed, it was shown among the sphingolipidoses that Tay-Sachs and Sandhoff GM2 gangliosidoses were due to separate genes encoding different subunits of the P-hexosaminidase enzyme (Rattazzi et al, 1976), and that sphingolipidoses can be due to structural gene or activator protein deficiencies (Kihara et al, 1984).…”
Section: Discussionmentioning
confidence: 99%
“…LOTS saccades are interrupted by transient decelerations, not always coming to a standstill, after which a new saccade occurs. In a mouse model of LOTS, GM2 storage is prominent in the motor cortex and cerebellum (granular cells and Purkinje cells), along with atrophy in the brainstem (Chern et al, 1976). Recent neuropathological studies of LOTS (Rucker et al, this volume) have demonstrated inclusions and reduction in metabolism in omnipause neurons (OPN), inclusions in fastigial nuclei (FN), and complete loss of Purkinje cells in the dorsal cerebellar vermis.…”
Section: Introductionmentioning
confidence: 99%